Sale

Intravenous Infusion Pump Market

Global Intravenous Infusion Pump Market Size, Trends, Report: By Type: Volumetric Infusion Pumps, Syringe Infusion Pumps, Patient Controlled Analgesia Infusion Pumps; By Applications: Oncology, Parenteral Nutrition, Analgesia/Pain Management, Others; By End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032

Global Intravenous Infusion Pump Market Outlook

The global intravenous infusion pump market size was valued at USD 5.3 billion in 2023, driven by the rising prevalence of chronic diseases across the globe. The market is expected to grow at a CAGR of 7.6% during the forecast period of 2024-2032, with the values likely to rise from USD 5.7 billion in 2024 to USD 10.2 billion by 2032.

 

Intravenous Infusion Pump: Introduction

An intravenous infusion pump is a device used to administer medication or fluids into a patient's body for treating high blood pressure. They offer significant advantage over manual administration as it capable of delivering fluids at precisely programmed intervals and in smaller volumes as well.

 

Infusion pumps can be stationary or portable depending on the patient’s requirement. Some pumps are equipped with safety measures like an alarm clock or other operator alerts as well. They may be mechanically or electrically powered.

 

Global Intravenous Infusion Pump Market Analysis

Intravenous infusion must be highly precise because even minute changes can threaten a patient's life. As a result, authorities like the FDA and EU continuously evaluate the efficacy of prevailing devices. To curb the high intravenous infusion pump market demand, prominent healthcare companies keep on bringing updated versions of devices.

 

Recently, FDA approved the redistribution of BD’s Alaris infusion pump in the market. This latest version is enabled with new software, hardware, and cybersecurity updates to deliver precise medications to the patients.

 

In August 2023, ICU Medical received 510(k) FDA clearance to its Plum Duo infusion pump, enabled with LifeShield infusion safety software. This pump features a large touch screen that enables an intuitive user interface as well. Similarly, Baxter’s Novum IQ syringe infusion pump (SYR) is paired with Dose IQ safety software that provides enhanced safety features, connectivity and a vast portfolio of sets designed to deliver optimum dose precision.

 

With a surge in innovations and digital integration into healthcare and medical devices, IOT (internet of things) controlled devices are set to emerge in the market. Researchers are working on developing remote monitoring enabled infusion pumps for accurate detection of patient’s vitals. Such technologies will enhance the intravenous infusion pump market growth in the upcoming years.

 

Global Intravenous Infusion Pump Market Segmentation

Market Breakup by Type

  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Patient Controlled Analgesia Infusion Pumps

 

Market Breakup by Applications

  • Oncology
  • Parenteral Nutrition
  • Analgesia/Pain Management
  • Others

 

Market Breakup by End User

  • Hospital and Clinics
  • Home Healthcare
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Applications
  • End User
  • Region
Breakup by Type
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Patient Controlled Analgesia Infusion Pumps
Breakup by Applications
  • Oncology
  • Parenteral Nutrition
  • Analgesia/Pain Management
  • Others
Breakup by End User
  • Hospital and Clinics
  • Home Healthcare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • B. Braun
  • Becton, Dickinson and Company
  • Baxter
  • Terumo Corporation
  • Medtronic Plc
  • Smith Medical
  • ICU Medical
  • Tandem Diabetes Care, Inc

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Intravenous Infusion Pump Market Overview 

    3.1    Global Intravenous Infusion Pump Market Historical Value (2017-2023) 
    3.2    Global Intravenous Infusion Pump Market Forecast Value (2024-2032)
4    Global Intravenous Infusion Pump Market Landscape
    4.1    Global Intravenous Infusion Pump: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Intravenous Infusion Pump: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Applications
5    Global Intravenous Infusion Pump Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Intravenous Infusion Pump Market Segmentation
    6.1    Global Intravenous Infusion Pump Market by Type
        6.1.1    Market Overview
        6.1.2    Volumetric Infusion Pumps
        6.1.3    Syringe Infusion Pumps
        6.1.4    Patient Controlled Analgesia Infusion Pumps
    6.2    Global Intravenous Infusion Pump Market by Applications
        6.2.1    Market Overview
        6.2.2    Oncology
        6.2.3    Parenteral Nutrition
        6.2.4    Analgesia/Pain Management
        6.2.5    Others
    6.3    Global Intravenous Infusion Pump Market by End User
        6.3.1    Market Overview
        6.3.2    Hospital and Clinics
        6.3.3    Home Healthcare
        6.3.4    Others
    6.4    Global Intravenous Infusion Pump Market by Region
        6.4.1    Market Overview
        6.4.2    North America
        6.4.3    Europe 
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Intravenous Infusion Pump Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Intravenous Infusion Pump Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Intravenous Infusion Pump Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Intravenous Infusion Pump Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Intravenous Infusion Pump Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding and Investment Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Supplier Landscape
    16.1    F. Hoffmann-La Roche Ltd.
        16.1.1    Financial Analysis
        16.1.2    Product Portfolio
        16.1.3    Demographic Reach and Achievements
        16.1.4    Mergers and Acquisitions
        16.1.5    Certifications 
    16.2    Fresenius SE & Co. KGaA
        16.2.1    Financial Analysis
        16.2.2    Product Portfolio
        16.2.3    Demographic Reach and Achievements
        16.2.4    Mergers and Acquisitions
        16.2.5    Certifications
    16.3    B. Braun 
        16.3.1    Financial Analysis
        16.3.2    Product Portfolio
        16.3.3    Demographic Reach and Achievements
        16.3.4    Mergers and Acquisitions
        16.3.5    Certifications
    16.4    Becton, Dickinson and Company
        16.4.1     Financial Analysis
        16.4.2    Product Portfolio
        16.4.3    Demographic Reach and Achievements
        16.4.4    Mergers and Acquisitions
        16.4.5    Certifications
    16.5    Baxter
        16.5.1    Financial Analysis
        16.5.2    Product Portfolio
        16.5.3    Demographic Reach and Achievements
        16.5.4    Mergers and Acquisitions
        16.5.5    Certifications
    16.6    Terumo Corporation
        16.6.1    Financial Analysis
        16.6.2    Product Portfolio
        16.6.3    Demographic Reach and Achievements
        16.6.4    Mergers and Acquisitions
        16.6.5    Certifications
    16.7    Medtronic Plc
        16.7.1    Financial Analysis
        16.7.2    Product Portfolio
        16.7.3    Demographic Reach and Achievements
        16.7.4    Mergers and Acquisitions
        16.7.5    Certifications
    16.8    Smith Medical
        16.8.1    Financial Analysis
        16.8.2    Product Portfolio
        16.8.3    Demographic Reach and Achievements
        16.8.4    Mergers and Acquisitions
        16.8.5    Certifications
    16.9    ICU Medical
        16.9.1    Financial Analysis
        16.9.2    Product Portfolio
        16.9.3    Demographic Reach and Achievements
        16.9.4    Mergers and Acquisitions
        16.9.5    Certifications
    16.10    Tandem Diabetes Care, Inc
        16.10.1    Financial Analysis
        16.10.2    Product Portfolio
        16.10.3    Demographic Reach and Achievements
        16.10.4    Mergers and Acquisitions
        16.10.5    Certifications
17    Key Opinion Leaders (KOL) Insights (Additional Insight)
18    Company Competitiveness Analysis (Additional Insight)

    18.1    Very Small Companies
    18.2    Small Companies
    18.3    Mid-Sized Companies
    18.4    Large Companies
    18.5    Very Large Companies
19    Payment Methods (Additional Insight)
    19.1    Government Funded
    19.2    Private Insurance
    19.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 5.3 billion in 2023, driven by the increasing incidence of chronic diseases across the globe.

The market is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032, likely to reach a market value of USD 10.2 billion by 2032.

The market demand has increased due to increased cases of chronic diseases, due to which patients have to undergo acute care facilities.

Infusion pumps enabled with cybersecurity have emerged in the market. In August 2023, ICU Medical gained 510(k) FDA clearance for their Plum Duo infusion pump, which is enabled with LifeShield infusion safety software. Baxter’s Novum IQ syringe infusion pump (SYR) is also paired with Dose IQ safety software to offer enhanced safety features, and connectivity.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps are available in the market.

Major end users include home healthcare, hospital and clinics, among others.

Common application areas include oncology, parenteral nutrition, and analgesia/pain management, among others.

Key players involved in the market are F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun, Becton, Dickinson and Company, Baxter, Terumo Corporation, Medtronic Plc, Smith Medical, ICU Medical and Tandem Diabetes Care, Inc.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER